Pharmaceutical company Indivor is facing the legal pressure of 36 attorneys general who claim that the company is holding an unethical monopoly, preventing a generic brand of a life-saving drug from being marketed and resulting in the loss of thousands of lives to opiate addiction. Of the 36 is Attorney General Brad Schimel of Wisconsin, who filed the lawsuit on Thursday, September 22.
Indivior is the maker of Suboxone, a drug that is prescribed to help treat opiate addictions. MonoSol Rx partnered with Indivior to help them create a dissolving film to replace the original tablet.
“Wisconsin and the nation are suffering hundreds and thousands of opiate-related deaths each year, and we cannot allow treatment barriers to exist for those suffering from addiction,” Schimel said.
A part of the legalese suggests that what Indivior is doing with their drug is illegal “product hopping,” which means that by making changes that don’t affect the integrity of the drug, the company can avoid giving up the patent.
To hold a monopoly on a life-saving drug can mean the difference between life and death for patients who cannot afford the name-brand version. At Habush Habush & Rottier S.C. ® we wholeheartedly believe you should receive the treatment you need within a reasonable time. If you have faced further illness or injury because of this failing, call us at (414) 271-0900 to set up a free consultation.